Blog Post by Admin
Presentation
Jun 14, 2023
Reuse health data safely via tech-enabled re-identification risk management
Braley Crandall, VP Operations, Replica Analytics
Start Reading
Blog
May 19, 2023
The Inflation Reduction Act Puts Real-World Evidence Front and Center
The drug price negotiation provisions of the Inflation Reduction Act (IRA) will ...
Start Reading
Presentation
May 9, 2023
Privacy Protective Sharing of Health Datasets using De-identification and Synthetic Data Generation
Start Reading
Blog
May 5, 2023
Aetion submits comments to FDA on recent draft guidance on considerations for externally controlled trials
Earlier this week, Aetion submitted a letter to FDA commenting on the Agency’s recent ...
Start Reading
Blog
May 3, 2023
Setting Real-World Standards at ISPOR 2023
Aetion joins other industry experts at ISPOR 2023 to discuss standard-setting and ...
Start Reading
Publication
May 1, 2023
Practical Synthetic Data Generation
This book published by O'Reilly is an introduction to synthetic data generation ...
Start Reading
Publication
May 1, 2023
A method for generating synthetic longitudinal health data
Getting access to administrative health data for research is difficult and time-consuming ...
Start Reading
Blog
Apr 27, 2023
Scientist spotlight: A deeper dive on RCT-DUPLICATE
This week, the final results of the RCT-DUPLICATE (RCT-D) study were published in the ...
Start Reading
Article
Feb 22, 2023
Synthetic data puts privacy at the heart of AI projects
This article in the Globe and Mail article provides a summary of the transformative role ...
Start Reading
Blog
Feb 15, 2023
Privacy Assurance FAQ
What is Privacy Assurance? One of the benefits of synthetic data is that it has low ...
Start Reading
Blog
Feb 15, 2023
Synthetic Data Generation FAQ
What is synthetic data generation (SDG)? There are many ways to generate synthetic data. ...
Start Reading
Blog
Feb 15, 2023
Aetion® Generate FAQ
What is Generate? Aetion® Generate, formerly Replica Synthesis, is Aetion’s scalable ...
Start Reading
Publication
Feb 14, 2023
Prescription opioid fills following surgical abortion
Objective To characterize opioid fills after surgical abortion among US ...
Start Reading
Publication
Feb 14, 2023
Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity.
Importance Algorithms for classification of inpatient COVID-19 severity are necessary for ...
Start Reading
Publication
Feb 14, 2023
Selective serotonin reuptake inhibitor use and perioperative bleeding and mortality in patients undergoing coronary artery bypass grafting: a cohort study
Introduction Several small studies have reported inconsistent findings about the safety ...
Start Reading
Publication
Feb 14, 2023
Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult male people with Hemophilia A without inhibitors
Aims To assess real-world use of emicizumab in adult people with hemophilia A (PwHA) ...
Start Reading
Publication
Feb 14, 2023
Categorization of COVID-19 severity to determine mortality risk
Purpose Algorithms for classification of inpatient COVID-19 severity are necessary for ...
Start Reading
Publication
Feb 14, 2023
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States
Introduction Head-to-head studies comparing COVID-19 mRNA vaccine effectiveness in ...
Start Reading
Publication
Feb 14, 2023
Treatment effectiveness in a rare oncology indication: lessons from an external control cohort study
Real-world data (RWD) reflecting patient treatment in routine clinical practice can be ...
Start Reading
Publication
Feb 14, 2023
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic
Objective To describe differences by race and ethnicity in treatment patterns among ...
Start Reading
Publication
Feb 14, 2023
A case for synthetic data in regulatory decision-making in Europe
Regulators are faced with many challenges surrounding health data usage, including ...
Start Reading
Publication
Feb 14, 2023
Uterine fibroids and incidence of depression, anxiety and self-directed violence: a cohort study
Background Depression and anxiety are prevalent among women with uterine fibroids (UF). ...
Start Reading
Publication
Feb 14, 2023
Graphical depiction of longitudinal study designs in health care databases
Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has become a ...
Start Reading
Publication
Feb 14, 2023
Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes
Background: Type 2 diabetes mellitus (T2DM) is a chronic condition with a high economic ...
Start Reading